Market Cap
$2.5B
PRVA
Privia Health Group, Inc.
$20.30 ▲ +1.35%
Prev close $20.03Market cap$2.5B
12-mo target$31.47 (+55.0%)
Insider Selling Cluster (2 insiders)High Impact Filing (7/10)23 New Institutional Positions17 Institutional Exits Healthcare & Medical Devices
Snapshot
The big-picture read on PRVA right now — valuation, ownership and activity at a glance.
Cap Size
Mid Cap
Inst. Holders
50 funds
Inst. Value
$2.3B
Inst. Activity
23 buys / 17 sells
Insider Activity
$0.00 buy / $15.7M sell
Insider Net $
-$15.7M
SEC Reports
14
Press Releases
1
Price chart 30d -1.8%
Daily candles (open–high–low–close) with volume. Green = up day, red = down day.
No data for this timeframe.
Vol
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Oct 1, 2026 short_volume
Short Volume: PRVA — 67.0% short (0.4M / 0.5M)
Short: 357,135 | Exempt: 31 | TRF Vol: 532,668 | Short Ratio: 67.0% | Off-exchange volume (dark pool
Sep 1, 2026 Insider
Jul 13, 2026 SEC Ernest Opella Finley was granted 6,350 shares
Director
Two PRVA insiders — Director Matthew Shawn Morris and CFO David Mountcastle — sold a combined $2.05M in open-market tran
CLUSTER — Impact 3/10
Two insiders at Privia Health sold shares in early July 2026, totaling ~$1.48M. The largest sale was a Director's open-m
CLUSTER — Impact 3/10
Jul 9, 2026 Insider
Jul 8, 2026 SEC Mountcastle David sold 21,275 shares
EVP & Chief Financial Officer @ $27.67 ($588.7K)
Two insiders at Privia Health sold a combined $2.05M in shares over a one-week window. Director Matthew Shawn executed a
CLUSTER — Impact 3/10
Jul 7, 2026 Insider
Mountcastle David sold 600 shares
EVP & Chief Financial Officer @ $27.57 ($16.5K)
Jun 30, 2026 Inst.
WELLINGTON MANAGEMENT GROUP LLP — DOUBLED
2,130,289 shares ($54.8M)
Analyst ratings buy % +3.4%
How Wall Street rates the stock today, and the latest firm-by-firm actions.
Recent analyst actions
| Date | Firm | Action | Rating | Firm rating |
|---|---|---|---|---|
| May 26, 2026 | Barclays | MAINTAIN | Equal-Weight | 54% |
| May 8, 2026 | Canaccord Genuity | MAINTAIN | Buy | 47% |
| Apr 8, 2026 | Evercore ISI Group | MAINTAIN | Outperform | 59% |
Monthly consensus history
| Period | Str. Buy | Buy | Hold | Sell | Str. Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Sep 1, 2026 | 8 | 15 | 2 | 0 | 0 | 92% | |
| Aug 1, 2026 | 8 | 15 | 3 | 0 | 0 | 88% | |
| Jul 1, 2026 | 8 | 15 | 3 | 0 | 0 | 88% | |
| Jun 1, 2026 | 9 | 15 | 3 | 0 | 0 | 89% | |
| May 1, 2026 | 9 | 15 | 3 | 0 | 0 | 89% | |
| Apr 1, 2026 | 9 | 16 | 3 | 0 | 0 | 89% | |
| Mar 1, 2026 | 9 | 16 | 3 | 0 | 0 | 89% | |
| Feb 1, 2026 | 9 | 16 | 3 | 0 | 0 | 89% |
Price targets
Where 17 covering analysts think PRVA trades over the next 12 months.
$31.47 +55.0% upside Strong Buy
Current$20.30 Low$24.00 Median$31.00 High$40.00 17 analysts
$24.00$40.00
Analyst rating Strong Buy· 1.4/5 as of Oct 2, 2026
Reports & filings
AI-scored summaries of recent SEC filings and press releases, with sentiment and impact.
14 SEC filing reports analyzed · 1 bullish, 3 bearish, 1 mixed, 9 neutral · avg impact 4.1/10.Plus 1 press releases.
NEUTRALCLUSTER3/10
Two PRVA insiders — Director Matthew Shawn Morris and CFO David Mountcastle — sold a combined $2.05M
Jul 13, 2026
NEUTRALCLUSTER3/10
Two insiders at Privia Health sold shares in early July 2026, totaling ~$1.48M. The largest sale was
Jul 10, 2026
NEUTRALCLUSTER3/10
Two insiders at Privia Health sold a combined $2.05M in shares over a one-week window. Director Matt
Jul 8, 2026
NEUTRALPRESS-RELEASE2/10
Privia Health Group announced it will release Q2 2026 financial results on August 6, 2026, before ma
Jul 7, 2026
Upcoming & catalyst events
Scheduled dates plus disclosed catalysts — earnings, dividends, enforcement, FDA and clinical-trial events. Colored dot = impact.
Oct 1, 2026
short_volume
Short Volume: PRVA — 67.0% short (0.4M / 0.5M)
Short: 357,135 | Exempt: 31 | TRF Vol: 532,668 | Short Ratio: 67.0% | Off-exchange volume (dark pool + OTC)
Sep 24, 2026
short_volume
Short Volume: PRVA — 67.8% short (0.4M / 0.6M)
Short: 389,430 | Exempt: 0 | TRF Vol: 574,000 | Short Ratio: 67.8% | Off-exchange volume (dark pool + OTC)
Aug 14, 2026
short_interest_report
Short Interest: PRVA up 38% to 5.3M shares
Settlement 2026-08-14 | Days to cover: 3.41 | ≈4.14% of shares outstanding (est.)
Aug 7, 2026
short_volume
Short Volume: PRVA — 61.3% short (0.6M / 1.0M)
Short: 609,840 | Exempt: 7,452 | TRF Vol: 995,399 | Short Ratio: 61.3% | Off-exchange volume (dark pool + OTC)
Aug 6, 2026
earnings
Privia Health Reports Strong Second Quarter and Year-to-Date 2026 Results
Privia Health Reports Strong Second Quarter and Year-to-Date 2026 Results; Full-Year 2026 Guidance Raised for All Key Financial Metrics
Earnings estimates
Forecast earnings per share and revenue by period — and whether estimates are rising.
| Period | EPS Est. | Range | Growth | 30d Rev | Up/Dn | Revenue | # |
|---|---|---|---|---|---|---|---|
| Current Q | $0.24 | $0.18–$0.32 | -16.1% | +0.9% | 5↑ 4↓ | $0.6B | 9 |
| Next Q | $0.24 | $0.18–$0.33 | -2.7% | +2.0% | 6↑ 2↓ | $0.6B | 9 |
| Current FY | $0.88 | $0.77–$1.24 | -10.7% | +0.9% | 3↑ 7↓ | $2.5B | 10 |
| Next FY | $1.06 | $0.85–$1.36 | 20.0% | -0.2% | 5↑ 5↓ | $2.7B | 10 |
Current-quarter EPS estimate — revision history
| When | EPS estimate | Change vs now |
|---|---|---|
| Current | $0.243 | — |
| 7d ago | $0.241 | +0.002 |
| 30d ago | $0.241 | +0.002 |
| 60d ago | $0.259 | -0.015 |
| 90d ago | $0.260 | -0.017 |
Institutional ownership
Which big funds own PRVA (from quarterly 13F filings) and who is adding or trimming.
50 institutional holders with $2.3B total value (88,167,602 shares) as of 2026-Q2. Top holders: BlackRock,, FMR, VANGUARD. Net buying activity: 23 institutions added/increased vs 17 reduced.
Top holders — 2026-Q2
| Fund | Shares | Value | % Tracked | Last move |
|---|---|---|---|---|
| BlackRock, Inc. | 21,402,417 | $550.7M | 24.3% | — |
| FMR LLC | 12,848,437 | $330.6M | 14.6% | — |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 6,572,384 | $169.1M | 7.5% | — |
| VANGUARD CAPITAL MANAGEMENT LLC | 5,156,720 | $132.7M | 5.8% | — |
| STATE STREET CORP | 4,905,789 | $126.2M | 5.6% | — |
| GEODE CAPITAL MANAGEMENT, LLC | 3,130,473 | $80.6M | 3.6% | — |
| Bank of New York Mellon Corp | 2,892,536 | $74.4M | 3.3% | — |
| PRINCIPAL FINANCIAL GROUP INC | 2,587,878 | $66.6M | 2.9% | — |
| DIMENSIONAL FUND ADVISORS LP | 2,551,861 | $65.7M | 2.9% | — |
| WELLINGTON MANAGEMENT GROUP LLP | 2,130,289 | $54.8M | 2.4% | DOUBLED +850.6% |
Recent position changes
| Fund | Action | Prev | Current | Change | Value |
|---|---|---|---|---|---|
| WELLINGTON MANAGEMENT GROUP LLP | DOUBLED | 224,102 | 2,130,289 | +850.6% | $54.8M |
| Nuveen, LLC | ADD | 948,136 | 1,465,145 | +54.5% | $37.7M |
| FORT WASHINGTON INVESTMENT ADVISORS INC /OH/ | DOUBLED | 189,611 | 1,053,271 | +455.5% | $27.1M |
| Qube Research & Technologies Ltd | ADD | 566,795 | 848,154 | +49.6% | $21.8M |
| Woodline Partners LP | ADD | 475,955 | 605,612 | +27.2% | $15.6M |
| D. E. Shaw & Co., Inc. | DOUBLED | 165,341 | 353,157 | +113.6% | $9.1M |
| BNP PARIBAS FINANCIAL MARKETS | ADD | 162,576 | 322,263 | +98.2% | $8.3M |
| UBS Group AG | TRIM | 381,785 | 285,210 | -25.3% | $7.3M |
| MILLENNIUM MANAGEMENT LLC | TRIM | 712,565 | 268,324 | -62.3% | $6.9M |
| Man Group plc | DOUBLED | 39,322 | 210,624 | +435.6% | $5.4M |
Insider activity
Buying and selling by company executives and directors (SEC Form 4).
11 insiders, 50 transactions. Net -$15.7M — $0.00 bought, $15.7M sold.
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Sep 1, 2026 | Ernest Opella Finley | Director | AWARD | 6,350 | — | — |
| Jul 9, 2026 | Mountcastle David | EVP & Chief Financial Officer | SELL | 21,275 | $27.67 | $588.7K |
| Jul 7, 2026 | Mountcastle David | EVP & Chief Financial Officer | SELL | 600 | $27.57 | $16.5K |
| Jul 6, 2026 | Morris Matthew Shawn | Director | EXERCISE | 53,722 | $2.00 | $107.4K |
| Jul 6, 2026 | Morris Matthew Shawn | Director | SELL | 53,722 | $27.24 | $1.5M |
| Jul 2, 2026 | Mountcastle David | EVP & Chief Financial Officer | SELL | 24,734 | $27.50 | $680.2K |
| Jul 2, 2026 | Morris Matthew Shawn | Director | EXERCISE | 59,037 | $2.00 | $118.1K |
| Jul 2, 2026 | Morris Matthew Shawn | Director | SELL | 59,037 | $27.33 | $1.6M |
| Jul 1, 2026 | Morris Matthew Shawn | Director | SELL | 45,634 | $26.52 | $1.2M |
| Jul 1, 2026 | Morris Matthew Shawn | Director | SELL | 37,041 | $26.93 | $997.5K |
Short interest & halts
FINRA semi-monthly short positions, Reg SHO threshold status, and recent trading halts for PRVA.
Shares short
4,900,411
Settlement Sep 15, 2026
Change vs prior
-10.2%
Semi-monthly cycle
Days to cover
4.0
At avg daily volume
Of shares outstanding
≈3.8%
Estimate — not % of float
All PRVA filing & press-release reports (15)
- CLUSTER reportJul 13, 2026
- CLUSTER reportJul 10, 2026
- CLUSTER reportJul 8, 2026
- PRESS-RELEASE reportJul 7, 2026
- CLUSTER reportJul 2, 2026
- PRESS-RELEASE reportMay 27, 2026
- 3 reportMay 22, 2026
- CLUSTER reportMay 13, 2026
- 8-K reportMay 7, 2026
- CLUSTER reportMay 6, 2026
- DEFA14A reportApr 2, 2026
- CLUSTER reportMar 18, 2026
- CLUSTER reportMar 16, 2026
- CLUSTER reportMar 10, 2026
- 8-K reportFeb 26, 2026